Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Heron Biotechnology is a specialized synthetic biology company that provides high-quality gene synthesis and DNA manufacturing services. Founded in 1999 and headquartered in Bothell, Washington, the company utilizes its proprietary GeneMaker platform to design and assemble complex DNA sequences, including those that are difficult to synthesize using standard methods. Their service portfolio includes custom gene synthesis, site-directed mutagenesis, cloning, and large-scale plasmid preparation. In 2010, Blue Heron was acquired by OriGene Technologies, and it currently operates as a key division within OriGene's genomic service offerings, supporting researchers in the pharmaceutical, biotechnology, and academic sectors worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Heron Biotechnology.